Mousallem Talal, Urban Thomas J, McSweeney K Melodi, Kleinstein Sarah E, Zhu Mingfu, Adeli Mehdi, Parrott Roberta E, Roberts Joseph L, Krueger Brian, Buckley Rebecca H, Goldstein David B
Departments of Internal Medicine and Pediatrics, Wake Forest School of Medicine, Winston-Salem, NC; Department of Pediatrics, Duke University Medical Center, Durham, NC.
Center for Human Genome Variation, Duke University School of Medicine, Durham, NC; Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC.
J Allergy Clin Immunol. 2015 Aug;136(2):476-9.e6. doi: 10.1016/j.jaci.2015.02.040. Epub 2015 May 14.
This report illustrates the value of whole genome sequencing (WGS) in elucidating the genetic cause of disease in patients with primary immunodeficiency (PID). As sequencing costs decline, we predict that utilization of next generation sequencing (NGS) in the clinical setting will increase.
本报告阐述了全基因组测序(WGS)在阐明原发性免疫缺陷(PID)患者疾病遗传病因方面的价值。随着测序成本的下降,我们预计临床环境中下一代测序(NGS)的应用将会增加。